ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2023

Transition Readiness over Time in a Rheumatology Transition Clinic

Meeting: ACR Convergence 2023

Keywords: education, patient, health behaviors, Health Services Research, Measurement Instrument, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: In 2018 we designed a Rheumatology Transition clinic to care for adolescent patients with autoimmune disease. We incorporate Health Care Transition curriculum (HCT) into our clinic to improve Transfer outcomes as patients move from a pediatric to adult healthcare model. As part of this HCT, we ask our participants to complete a Transition Readiness Assessment (TRA) that mirrors the same assessment available from the GotTransition website. This assessment quantifies a patient’s preparedness to become independent in managing their own health care. This abstract presents preliminary data from the TRA, contrasting responses over time in individual patients and parents, and the responses from the patients versus their parents or legal guardians.

Methods: Participants are asked to complete the TRA. The TRA is requested at two time points. First, when patients are first evaluated. Second, just before their first clinical visit with an adult Rheumatologist in an adult Rheumatology clinic.

Responses from the patients at the two time points were evaluated and compared using appropriate statistical analyses. To assess the significance of changes in responses over time, a t-test was conducted to compare the patients’ first and second answers. The mean (SD) was calculated to summarize the age at diagnosis, age at enrollment, and the number of days from the first survey to the second survey. Additionally, the median (interquartile range, IQR) and range were used to summarize the distribution of these variables. Categorical variables such as sex, gender identity, race, and ethnicity were summarized using N (%) to indicate the number and percentage of patients within each category.

Results: As of May 2023, we had 129 patient and 95 parent participants in the first TRA; and 27 patient and 15 parent participants in the second TRA (Table 1: Patient demographics). In all but two variables, patients and parents report improvement in Transition readiness. Patients report better Transition readiness, than do parents, when they are first enrolled into the registry. Where there is a statistically significant disparity between patients and parents in their assessment, it is patients who report better Transition readiness at registry enrollment. However, where there is a statistically significant disparity in their assessment over time, it is parents who are more likely to report a longitudinal improvement in their child’s Transition readiness over time (Figure 1: TRA responses over time).

Conclusion: These findings alone do not prove a causative effect between the HCT curriculum in our Transition clinic and improved Transition readiness over time. However, this improvement in Transition readiness over time is encouraging. Potential confounders might include an independent progression in maturity and independence with age that might also improve Transition readiness. In our future research, we will work to understand patient-specific variables that influence improved Transition readiness, and if there is a correlation with Transition readiness and Transfer and medical outcomes.

Supporting image 1

Supporting image 2

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transition-readiness-over-time-in-a-rheumatology-transition-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology